ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.8631A>G (p.Glu2877=) (rs1064796223)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000483233 SCV000572736 uncertain significance not provided 2017-01-17 criteria provided, single submitter clinical testing This variant is denoted BRCA2 c.8631A>G at the DNA level. Although the variant is silent at the coding level, preserving a Glutamic Acid at codon 2877, it is predicted to damage the nearby natural splice donor site and cause abnormal splicing. However, in the absence of RNA or functional studies, the actual effect of this variant is unknown. Also defined as BRCA2 8859A>G using alternate nomenclature, this variant has not, to our knowledge, been published in the literature as pathogenic or benign. BRCA2 c.8631A>G was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. The nucleotide which is altered, an adenine (A) at base 8631, is not conserved. Based on currently available evidence, it is unclear whether BRCA2 c.8631A>G is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.